Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Completed · Phase 3

Conditions studied: Alzheimer's Disease, Dementia, Alzheimer Type

In brief

The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.

Key facts

Study ID

NCT00099242

Run by

Novartis Pharmaceuticals

People needed

1040

Starts

2003-11-01

Expected to finish

2006-01-01

Last updated by the study team

2017-10-13

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of dementia of the Alzheimer's type
• Males, and females who are surgically sterile or one year postmenopausal
• A primary caregiver willing to accept responsibility for supervising the treatment

You may not qualify if…

• Any condition (other than Alzheimer's) that could explain patient's dementia
• An advanced, severe or unstable disease that may put the patient at special risk
• Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular disease

Where it is running

• Study site — Oslo, Norway
• Study site — Tromsø, Norway
• Study site — Trondheim, Norway
• Study site — Lima, Peru
• Study site — Gdansk, Poland
• Study site — Lublin, Poland
• Study site — Poznan, Poland
• Study site — Szczecin, Poland
• Study site — Warsaw, Poland
• Study site — Amadora, Portugal
• Study site — Coimbra, Portugal
• Study site — Bayamón, Puerto Rico
• Study site — Moscow, Russia
• Study site — Saint Petersburg, Russia
• Study site — Bratislava, Slovakia
• Study site — Michalovce, Slovakia
• Study site — KyungKi-province, South Korea
• Study site — Seoul, South Korea
• Study site — Taebuk, South Korea
• Study site — Gothenburg, Sweden
• Study site — Kalmar, Sweden
• Study site — Stockholm, Sweden
• Study site — Uppsala, Sweden
• Study site — Kaohsiung City, Taiwan
• Study site — Bodø, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.